APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Growth and Trends Forecast to 2032

Report ID 174045330119 December 202588 pages

Choose your research edition.

Industry ResearchVaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market include Novartis AG, Pfizer Inc, AstraZeneca Plc, Seattle Genetics Inc, NuvOx Pharma LLC, Modus Therapeutics Holding AB, Gilead Sciences Inc and Bristol-Myers Squibb Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market by Company

Novartis AG

Pfizer Inc

AstraZeneca Plc

Seattle Genetics Inc

NuvOx Pharma LLC

Modus Therapeutics Holding AB

Gilead Sciences Inc

Bristol-Myers Squibb Company

Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Segment by Type

SGD-2083

Crizanlizumab

PF-04447943

NVX-508

Others

Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Segment by Application

Clinic

Hospital

Others

Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Region (2021-2026) Table 4. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Region (2027-2032) Table 6. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share by Type (2021-2026) Table 9. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share by Application (2021-2026) Table 24. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Trends Table 37. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Drivers Table 38. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Opportunities and Challenges Table 39. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Restraints Table 40. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share by Company (2021-2026) Table 42. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Key Company Headquarters & Area Served Table 44. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Company, Product Type & Application Table 45. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Novartis AG Company Information Table 49. Novartis AG Business Overview Table 50. Novartis AG Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Novartis AG Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio Table 52. Novartis AG Recent Development Table 53. Pfizer Inc Company Information Table 54. Pfizer Inc Business Overview Table 55. Pfizer Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Pfizer Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio Table 57. Pfizer Inc Recent Development Table 58. AstraZeneca Plc Company Information Table 59. AstraZeneca Plc Business Overview Table 60. AstraZeneca Plc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. AstraZeneca Plc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio Table 62. AstraZeneca Plc Recent Development Table 63. Seattle Genetics Inc Company Information Table 64. Seattle Genetics Inc Business Overview Table 65. Seattle Genetics Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Seattle Genetics Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio Table 67. Seattle Genetics Inc Recent Development Table 68. NuvOx Pharma LLC Company Information Table 69. NuvOx Pharma LLC Business Overview Table 70. NuvOx Pharma LLC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. NuvOx Pharma LLC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio Table 72. NuvOx Pharma LLC Recent Development Table 73. Modus Therapeutics Holding AB Company Information Table 74. Modus Therapeutics Holding AB Business Overview Table 75. Modus Therapeutics Holding AB Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Modus Therapeutics Holding AB Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio Table 77. Modus Therapeutics Holding AB Recent Development Table 78. Gilead Sciences Inc Company Information Table 79. Gilead Sciences Inc Business Overview Table 80. Gilead Sciences Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Gilead Sciences Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio Table 82. Gilead Sciences Inc Recent Development Table 83. Bristol-Myers Squibb Company Company Information Table 84. Bristol-Myers Squibb Company Business Overview Table 85. Bristol-Myers Squibb Company Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Bristol-Myers Squibb Company Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio Table 87. Bristol-Myers Squibb Company Recent Development Table 88. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 90. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2021-2026) Table 91. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share Forecast by Country (2027-2032) Table 93. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 95. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2021-2026) Table 96. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share Forecast by Country (2027-2032) Table 98. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 100. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2021-2026) Table 101. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share Forecast by Country (2027-2032) Table 103. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 105. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2021-2026) Table 106. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share Forecast by Country (2027-2032) Table 108. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 110. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2021-2026) Table 111. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share Forecast by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Image Figure 3. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Region (2021-2032) Figure 7. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. SGD-2083 Image Figure 13. Global SGD-2083 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Crizanlizumab Image Figure 15. Global Crizanlizumab Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. PF-04447943 Image Figure 17. Global PF-04447943 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. NVX-508 Image Figure 19. Global NVX-508 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Type 2025 VS 2032 Figure 24. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share by Type (2021-2032) Figure 25. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share by Type (2021-2032) Figure 27. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share by Type (2021-2032) Figure 29. Clinic Image Figure 30. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Hospital Image Figure 32. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Application 2025 VS 2032 Figure 37. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share by Application (2021-2032) Figure 38. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share by Application (2021-2032) Figure 40. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2021-2032) Figure 47. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2021-2032) Figure 50. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2021-2032) Figure 53. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2021-2032) Figure 56. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • SGD-2083
  • Crizanlizumab
  • PF-04447943
  • NVX-508
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Novartis AG
  • Pfizer Inc
  • AstraZeneca Plc
  • Seattle Genetics Inc
  • NuvOx Pharma LLC
  • Modus Therapeutics Holding AB
  • Gilead Sciences Inc
  • Bristol-Myers Squibb Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (2021-2032)
  8. 1.5.1 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (2021-2032)
2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 SGD-2083
  3. 2.1.2 Crizanlizumab
  4. 2.1.3 PF-04447943
  5. 2.1.4 NVX-508
  6. 2.1.5 Others
  7. 2.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type
  8. 2.2.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Regions
  12. 2.3.1 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Type (2021-2026)
3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Clinic
  3. 3.1.2 Hospital
  4. 3.1.3 Others
  5. 3.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application
  6. 3.2.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Regions
  10. 3.3.1 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Trends
  2. 4.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Drivers
  3. 4.3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Opportunities and Challenges
  4. 4.4 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (2021-2026)
  2. 5.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Key Company Headquarters & Area Served
  4. 5.4 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Company, Product Type & Application
  5. 5.5 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Pfizer Inc
  8. 6.2.1 Pfizer Inc Company Information
  9. 6.2.2 Pfizer Inc Business Overview
  10. 6.2.3 Pfizer Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio
  12. 6.2.5 Pfizer Inc Recent Developments
  13. 6.3 AstraZeneca Plc
  14. 6.3.1 AstraZeneca Plc Company Information
  15. 6.3.2 AstraZeneca Plc Business Overview
  16. 6.3.3 AstraZeneca Plc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 AstraZeneca Plc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio
  18. 6.3.5 AstraZeneca Plc Recent Developments
  19. 6.4 Seattle Genetics Inc
  20. 6.4.1 Seattle Genetics Inc Company Information
  21. 6.4.2 Seattle Genetics Inc Business Overview
  22. 6.4.3 Seattle Genetics Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Seattle Genetics Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio
  24. 6.4.5 Seattle Genetics Inc Recent Developments
  25. 6.5 NuvOx Pharma LLC
  26. 6.5.1 NuvOx Pharma LLC Company Information
  27. 6.5.2 NuvOx Pharma LLC Business Overview
  28. 6.5.3 NuvOx Pharma LLC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 NuvOx Pharma LLC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio
  30. 6.5.5 NuvOx Pharma LLC Recent Developments
  31. 6.6 Modus Therapeutics Holding AB
  32. 6.6.1 Modus Therapeutics Holding AB Company Information
  33. 6.6.2 Modus Therapeutics Holding AB Business Overview
  34. 6.6.3 Modus Therapeutics Holding AB Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Modus Therapeutics Holding AB Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio
  36. 6.6.5 Modus Therapeutics Holding AB Recent Developments
  37. 6.7 Gilead Sciences Inc
  38. 6.7.1 Gilead Sciences Inc Company Information
  39. 6.7.2 Gilead Sciences Inc Business Overview
  40. 6.7.3 Gilead Sciences Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Gilead Sciences Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio
  42. 6.7.5 Gilead Sciences Inc Recent Developments
  43. 6.8 Bristol-Myers Squibb Company
  44. 6.8.1 Bristol-Myers Squibb Company Company Information
  45. 6.8.2 Bristol-Myers Squibb Company Business Overview
  46. 6.8.3 Bristol-Myers Squibb Company Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Bristol-Myers Squibb Company Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Portfolio
  48. 6.8.5 Bristol-Myers Squibb Company Recent Developments
7 North America
  1. 7.1 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2021-2026)
  3. 7.3 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2021-2026)
  3. 10.3 South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst